Verrica Pharmaceuticals Inc (NASDAQ:VRCA)

Delayed Data
As of Dec 05
 -0.01 / -0.30%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Verrica Pharmaceuticals Inc have a median target of 10.50, with a high estimate of 15.00 and a low estimate of 4.00. The median estimate represents a +213.43% increase from the last price of 3.35.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Verrica Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 29.69%


Growthquarterly -96.24%
Growthannually -38.14%
Key to the earnings and sales forecast charts.